Literature DB >> 21214702

Familial mild hyperglycemia associated with a novel ABCC8-V84I mutation within three generations.

Lucie Gonsorcikova1, Martine Vaxillaire, Stepanka Pruhova, Aurélie Dechaume, Petra Dusatkova, Ondrej Cinek, Oluf Pedersen, Philippe Froguel, Torben Hansen, Jan Lebl.   

Abstract

We present a unique case of a 19-year-old man with a positive family history of persistent mild hyperglycemia and a novel V84I mutation in ABCC8. The proband was initially detected to have fasting hyperglycemia (ranging 6.1-6.4 mmol/L) at the age of 12 years. Increased fasting blood glucose was also subsequently detected in five additional family members (in his twin brother, sister, mother, maternal aunt, and grandfather). The grandfather has been known to have mild diabetes since 30 years and has never been treated. After having excluded a causative mutation in five maturity-onset diabetes of the young genes (MODY1-4 and 6), we identified a novel ABCC8 V84I mutation, which segregated with autosomal dominant transmission of mild hyperglycemia within three generations. This mutation that is located in a conserved area of transmembrane domain TMD0 seems to be a rare cause of clinical phenotype resembling glucokinase-deficient diabetes.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214702     DOI: 10.1111/j.1399-5448.2010.00719.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  7 in total

Review 1.  Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.

Authors:  Siri Atma W Greeley; Rochelle N Naylor; Louis H Philipson; Graeme I Bell
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

2.  Frequency and spectrum of glucokinase mutations in an adult Maltese population.

Authors:  Nikolai Paul Pace; Celine Ann Grech; Barbara Vella; Ruth Caruana; Josanne Vassallo
Journal:  Acta Diabetol       Date:  2021-10-22       Impact factor: 4.280

3.  ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective.

Authors:  Alla K Ovsyannikova; Oksana D Rymar; Elena V Shakhtshneider; Vadim V Klimontov; Elena A Koroleva; Natalya E Myakina; Mikhail I Voevoda
Journal:  Diabetes Ther       Date:  2016-08-18       Impact factor: 2.945

4.  Case Report: A Novel ABCC8 Variant in a Chinese Pedigree of Maturity-Onset Diabetes of the Young.

Authors:  Chaoyan Tang; Liheng Meng; Ping Zhang; Xinghuan Liang; Chaozhi Dang; Hui Liang; Junfeng Wu; Haiyun Lan; Yingfen Qin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

5.  Clinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review.

Authors:  Meng Li; Xueyao Han; Linong Ji
Journal:  J Diabetes Res       Date:  2021-09-30       Impact factor: 4.011

Review 6.  New insights into KATP channel gene mutations and neonatal diabetes mellitus.

Authors:  Tanadet Pipatpolkai; Samuel Usher; Phillip J Stansfeld; Frances M Ashcroft
Journal:  Nat Rev Endocrinol       Date:  2020-05-06       Impact factor: 43.330

Review 7.  Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes.

Authors:  Antonella Marucci; Irene Rutigliano; Grazia Fini; Serena Pezzilli; Claudia Menzaghi; Rosa Di Paola; Vincenzo Trischitta
Journal:  Genes (Basel)       Date:  2022-01-09       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.